title: Screening and intervention for treatment-related cardiac dysfunction in childhood cancer survivors.
authors.affiliation: Department of Oncology, St Jude Children's Research Hospital, Memphis, TN 381053, USA.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Ehrhardt
authors.affiliation: Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
authors.forename: Saro H
authors.initials: SH
authors.lastname: Armenian
authors.affiliation: Division of Pediatric Hematology, Oncology & Bone Marrow Transplantation, Children's Mercy, Kansas City, MO 64108, USA.
authors.forename: Joy M
authors.initials: JM
authors.lastname: Fulbright
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy; D002648:Child; D004452:Echocardiography; D017408:Guidelines as Topic; D006801:Humans; D000077550:Ivabradine; D009369:Neoplasms / Q000150:complications / Q000401:mortality / Q000628:therapy*; D017741:Survivors; D019210:Troponin I / Q000097:blood; D020107:Troponin T / Q000097:blood
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001552:Benzazepines; D015415:Biomarkers; D019210:Troponin I; D020107:Troponin T; D000077550:Ivabradine
keywords: anthracyclines; cardiac dysfunction; chest radiation; childhood cancer survivors; late effects; prevention; screening; treatment